|
|
||||||||
From the Institute of Pathology, Western Pennsylvania Hospital, Pittsburgh
Abstract
The current status of the Rh hapten has been described, first, as to preparation; second, as regards assay; third, in relation to its nature and properties and finally, a preliminary account of its clinical application has been presented. It is advocated that initial ventures with clinical use be interpreted with great caution.
Footnotes
* This work was supported in part by a grant from Eli Lilly and Company, Indianapolis, Indiana.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |